Protection of calves against fatal enteric colibacillosis by orally administered Escherichia coli K99-specific monoclonal antibody
David Μ. Sherman(University of Minnesota), Charles C. Muscoplat(Utah State University), Jan Springer, T. J. G. Raybould, S D Acres(University of Minnesota), Peter L. Sadowski(University of Minnesota), Bonnie Anderson Bray
Cited by 102
Related Papers
Oral Pilocarpine for Post-Irradiation Xerostomia in Patients with Head and Neck Cancer
|New England Journal of Medicine|1993|483
A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients.
|Journal of Clinical Oncology|1993|292
Oral pilocarpine for radiation-induced xerostomia: Integrated efficacy and safety results from two prospective randomized clinical trials
|International Journal of Radiation Oncology*Biology*Physics|1995|139
Preclinical antitumor activity of 6-hydroxymethylacylfulvene, a semisynthetic derivative of the mushroom toxin illudin S.
|PubMed|1997|109
Maternal Immunity to Infectious Bovine Rhinotracheitis and Bovine Viral Diarrhea Viruses: Duration and Effect on Vaccination in Young Calves
|American Journal of Veterinary Research|1978|86